Company Filing History:
Years Active: 2011-2015
Title: Xiping Liu: Innovator in Cancer Treatment
Introduction
Xiping Liu is a prominent inventor based in Temple City, CA (US). He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 3 patents, Liu's work focuses on advancing therapeutic techniques that target cancerous tumors.
Latest Patents
Liu's latest patents include groundbreaking inventions such as the use of the SPARC microenvironment signature in the treatment of cancer. This invention provides multiparametric anti-SPARC antibody-based techniques for predicting the response to chemotherapy. Another notable patent is the development of SPARC binding antibodies that target disease sites, particularly tumors, and their uses in diagnosing and treating diseases, especially cancerous tumors.
Career Highlights
Throughout his career, Liu has worked with notable companies in the biotechnology sector, including Abraxis Bioscience, LLC and Mannkind Corporation. His experience in these organizations has allowed him to refine his expertise in cancer research and treatment.
Collaborations
Liu has collaborated with esteemed colleagues such as Vuong Trieu and Neil P Desai, contributing to the advancement of cancer therapies through shared knowledge and innovation.
Conclusion
Xiping Liu's contributions to cancer treatment through his patents and collaborations highlight his dedication to improving patient outcomes. His innovative approaches continue to pave the way for advancements in the medical field.